Insights On Outsourced Drug Development
-
EMA Support For Rare Disease Therapies
6/10/2025
Review how the EMA supports rare disease drug development through regulatory and financial incentives for therapies that meet strict eligibility and ongoing compliance criteria.
-
Comprehensive And Streamlined Genomic Signature Assessment
6/9/2026
Simultaneous analysis of HRD, TMB, and MSI offers a more complete view of tumor biology. A modular sequencing approach enables efficient workflows, conserves samples, and delivers deeper insights.
-
Overcoming Challenges To High-Concentration Formulation Development
3/25/2025
Explore how the S-HiCon™ platform optimizes high-concentration therapeutic antibody formulations, overcoming stability and manufacturability challenges to deliver safe, effective therapies.
-
Improving The Efficiency And Quality Of Advanced Imaging And Analysis
8/27/2025
Human-relevant models are transforming drug screening. Find out how overcoming 3D cell culture challenges with integrated innovations accelerates discovery and brings effective treatments to patients faster.
-
Epigenetics Application Guide
10/2/2024
To fully understand biology and disease mechanisms, it is crucial to explore the role of epigenetic factors. Explore how epigenetic regulation works and methods to study these essential components.
-
Advancing Drug Development With Optimized LC-MS/MS Bioanalysis
5/7/2025
Explore the critical role of sample preparation optimization and the application of liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) in bioanalytical method development.
-
Aggregate Analysis Of Tirzepatide
12/11/2025
A new size exclusion method effectively analyzes Tirzepatide aggregates, demonstrating robust separation and reproducibility with minimal need for organic solvents or acidic modifiers.
-
Direct Amplification Of Research Samples
6/15/2026
Skip time-consuming extraction steps and achieve reliable qPCR results. Direct amplification methods help researchers detect respiratory pathogens more efficiently across saliva and nasal samples.
-
Addressing Raw Material Handling Challenges By Dry Granulation
8/12/2025
Handling multi-ton quantities of buffers, salts, and stabilizing chemicals in manufacturing can be difficult. Discover how dry granulation improves efficiency, safety, and process reliability.
-
Scale-Up Of A Transient rAAV Production Process
11/3/2025
Scalable rAAV production is achievable with a transient cell line and optimized bioreactor setup, delivering high titers and reduced impurities, now validated at 200 L scale for commercial readiness.